SCHEMBL17201436

SCHEMBL17201436

Cc1ccc(COc2ccc(-c3ccon3)cc2)cc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP19A1 P11511 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
NPC1 O15118 7/20 0.46
RAB9A P51151 7/20 0.46
ENPP3 O14638 1/20 0.40
ENPP1 P22413 1/20 0.40
THRB P10828 2/20 0.40
MAPT P10636 6/20 0.39
TSHR P16473 1/20 0.39
HSP90AA1 P07900 1/20 0.39
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ESR1 P03372 1/20 0.38
TP53 P04637 1/20 0.38
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201420 0.82 CYP1A2 (0.60) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201421 0.81 CYP1A2 (0.52) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15774756 0.79 CYP1A2 (0.56) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201432 0.78 CYP1A2 (0.58) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201438 0.77 MAOB (0.56) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201427 0.77 DHFR (0.56) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15774879 0.76 CYP1A2 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15774728 0.76 NPC1 (0.51) NPC1RAB9AMAPTHSP90AA1POLB
SCHEMBL29840623 0.76 NPC1 (0.53) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15774634 0.75 CYP1A2 (0.43) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296711-B2 Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1) HOFFMAN-LA ROCHE INC. (US) 2016-03-29 US disclosed
US-20150307463-A1 SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1) HOFFMANN-LA ROCHE INC. 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307463-A1 SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1) SCD, SCD5, CPT1A CYP1A2 368/4885CYP2D6 747/4885CYP19A1 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.